Elite in Hyperaldosteronism

Vin-cent C. Wu

7 Chung Shan South Road, 100, 
TPQ, TW 
Elite in Hyperaldosteronism
7 Chung Shan South Road, 100, 
TPQ, TW 
OverviewLocationsClinical Research

Overview

Vin-cent Wu practices in Taiwan. Mr. Wu is rated as an Elite expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Hyperaldosteronism, Glucocorticoid-Remediable Aldosteronism, Adrenal Gland Adenoma, Heart Bypass Surgery, and Nephrectomy.

His clinical research consists of co-authoring 370 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 187 articles in the study of Hyperaldosteronism.

Gender
Male

Locations

7 Chung Shan South Road, 100, TPQ, Taiwan
Other Locations
No. 7, Chung Shan South Road, TPQ 10002, Taiwan
No. 7, Zhongshan S. Rd, TPQ, Taiwan
No.1, Changde St, Zhongzheng Dist, TPQ 10048, Taiwan
No.7, Chung Shan South Road, 100, TPQ, Taiwan
No. 1, Sec 1, Ren Ai Road, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 3

370 Total Publications

Pregnancy-associated acute kidney injury - consensus report of the 32nd Acute Disease Quality Initiative workgroup.
Pregnancy-associated acute kidney injury - consensus report of the 32nd Acute Disease Quality Initiative workgroup.
Journal: Nature reviews. Nephrology
Published: June 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wu's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile